⚜Rvasus⚜

Active Pharmaceutical Ingredients Market The active pharmaceutical ingredients (API) industry is growing due to increased demand and R & D investment. It is a highly competitive market, often volatile, but with many opportunities. Highly potent APIs are expected to drive further demand in the near future, especially in the oncology segment. The significant dependency on China is one of the industry's biggest threats. As required, some selected insights concerning regulatory hurdles were included in the SWOT analysis. However, the API market has a complex regulatory framework, and guidelines change according to the market, product and authority involved; therefore, it was only possible to provide a brief overview of some relevant barriers. SWOT Analysis Strengths Recent biological and digital technologies are strengthening the API market, which has seen steady growth over the last few years due to an aging global population and the emergence of chronic ailments that require med...

Some insights into legislation that is limiting the deployment of WiFi in schools because of health concerns brought about by RF emissions include the banning of WiFi in France's Pre nursery/Nursery schools, state legislation in the US that prohibit cell towers in schools, new guidelines regarding Wi-Fi use in schools in Israel, and the RNCNIRP resolution in Russia. FRANCE: WiFi Banned in Pre nursery/Nursery Schools On January 29, 2015, the French National Assembly passed a new national law to reduce exposures to wireless radiation electromagnetic fields. According to the legislation, WiFi is banned in Pre-Nursery and Nursery Schools. The law states that "WIFI and Wireless devices will be banned in the spaces dedicated to home, to rest and activities of children under 3 years."

Medical Food Labeling and Ingredient Requirements Even though the commercialization of medical foods  does not require FDA approval , the agency has published a  guidance document  for the industry (last updated in  May 2016 ). Barring specific exemptions, medical foods are required to comply with all  applicable food labeling requirements . The ingredients added to these products should be “ safe  and in compliance with all applicable provisions of the FD&C Act and FDA regulations.” Overview of FDA’s Regulations for the Medical Foods Industry Medical food manufacturers are  not required  to seek the approval of FDA to commercialize their products. As medical foods are not drugs, they are “not subject to any regulatory requirements that specifically apply to  drugs .”  FDA’s Office of Nutrition and Food Labeling has published a  guidance document  for the medical foods industry.  FDA’s guidance documents “do no...

Medical Food Case Studies Metagenics is a medical foods company with over 30 years of experience, while Axona is a brand of Cerecin, a company with over 20 years of experience. Complete case studies for each medical food brand are presented below. Metagenics Who the Brand Is   Metagenics has operated for more than 30 years as a functional nutrition company with the dedication to do scientific discovery and practitioner partnerships with unparalleled quality. The company has made more than 300 solutions for scientifically formulated foods and 87 research publications in PubMed. More than $7 million has been spent in research and development with more than 100,000 partnerships all around the world. What They Provide in the Medical Food Space   UltraInflamX Plus 360° supports the nutritional management of gut function resulting from inflammatory bowel disease.   UltraGI Replenish supports the management of gut function in response to digestive disorders including malabsorp...